Axsome Therapeutics (AXSM) Long-Term Debt Repayments (2018 - 2026)
Axsome Therapeutics (AXSM) posted Long-Term Debt Repayments of $70 million for Q2 2026, down 63.5% from $191.59 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Long-Term Debt Repayments (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Long-Term Debt Repayments at Axsome Therapeutics was $280 million, up 45.4% year-over-year; for FY2025, it came in at $331.99 million.
- Annual Long-Term Debt Repayments shows a five-year compound annual growth rate of 72.6% (FY2020 to FY2025).
- In prior years, Axsome Therapeutics' Long-Term Debt Repayments was $990,000 in FY2024.
- Quarterly Long-Term Debt Repayments has run from a low of $163,000 in Q1 2024 to a high of $191.59 million in Q2 2025 over five years.
- According to Business Quant data, Long-Term Debt Repayments for the three prior quarters was $70 million (Q1 2026), $70 million (Q4 2025) and $70 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Axsome Therapeutics | 8.09 Bn | 6.82 Bn | 204.81 Mn | 71.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.21 Mn |
| Mar 31, 2026 | 70.67 Mn |
| Dec 31, 2025 | 70.54 Mn |
| Sep 30, 2025 | 70.66 Mn |
| Jun 30, 2025 | 192.51 Mn |
| Mar 31, 2025 | 401,000.00 |
| Dec 31, 2024 | 330,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | 186,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Mar 31, 2019 | 7.24 Mn |
| Dec 31, 2018 | 833,333.00 |
| Sep 30, 2018 | 833,333.00 |
| Jun 30, 2018 | 833,334.00 |
| Mar 31, 2018 | 833,333.00 |
API Access
Axsome Therapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();